← Browse by Condition
Medical Condition
t cell histiocyte rich large b cell lymphoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT04231877 Phase 1
Recruiting
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma
Enrollment
56 pts
Location
United States
Sponsor
University of Washington
NCT07097363 Phase 2
Recruiting
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
Enrollment
18 pts
Location
United States
Sponsor
University of Washington